The generation of the mammalian heartbeat is a complex and vital function requiring multiple and coordinated ionic channel activities. The functional role of low-voltage activated (LVA) T-type calcium channels in the pacemaker activity of the sinoatrial node (SAN) is, to date, unresolved. Here we show that disruption of the gene coding for Ca v 3.1/␣ 1G T-type calcium channels (cacna1g) abolishes T-type calcium current (I Ca,T ) in isolated cells from the SAN and the atrioventricular node without affecting the L-type Ca 2ϩ current (I Ca,L ). By using telemetric electrocardiograms on unrestrained mice and intracardiac recordings, we find that cacna1g inactivation causes bradycardia and delays atrioventricular conduction without affecting the excitability of the right atrium. Consistently, no I Ca,T was detected in right atrium myocytes in both wild-type and Ca v 3.1 Ϫ/Ϫ mice. Furthermore, inactivation of cacna1g significantly slowed the intrinsic in vivo heart rate, prolonged the SAN recovery time, and slowed pacemaker activity of individual SAN cells through a reduction of the slope of the diastolic depolarization. Our results demonstrate that Ca v 3.1/T-type Ca 2ϩ channels contribute to SAN pacemaker activity and atrioventricular conduction.
T he initiation of the heartbeat requires coordination between the automaticity of the sinoatrial node (SAN) and excitability of the atrioventricular (AV) conduction tissue: the AV node (AVN) and the His-Purkinje fiber network. SAN automaticity is caused by the presence of the diastolic depolarization. 1 Multiple classes of ionic channels are expressed in the SAN, 1,2 but the precise mechanism initiating the diastolic depolarization has not been entirely elucidated, and the relative contribution of different ionic channels in establishing the heart rate under specific physiological conditions is still a matter of debate. [3] [4] [5] Strong functional, pharmacological, and genetic evidence show that the hyperpolarization-activated currents I f 6,7 and I Ca,L 8 -10 play major roles in controlling the diastolic depolarization after decaying of the fast component of delayed-rectifier K ϩ currents (I Kr ). Diastolic release of Ca 2ϩ mediated by ryanodine receptors (RyRs) has been indicated as an important mechanism for controlling SAN pacemaking under activation of the ␤-adrenergic receptor. 11 The SAN also expresses neuronal tetrodotoxin (TTX)-sensitive and cardiac TTX-resistant voltage-dependent Na ϩ currents (I Na ). 12 TTX-sensitive I Na is involved in SAN pacemaking in the newborn rabbit 13 and in the adult mouse. 12, 14 The cardiac TTX-resistant SCN5Amediated I Na is important for conduction from the SAN to the atrium and in intranodal conduction. 15 I Na is also expressed in the rabbit 16 and guinea pig 17 AVN and contributes to the fast AV conduction pathway. 18 Consistently, heterozygous mice lacking SCN5A channels have major AV conduction dysfunction. 19 I Ca,T has also been proposed to contribute to pacemaking in primary SAN 20 as well as in latent pacemaker cells of the right atrium (RA). 21 I Ca,T is expressed in pacemaker cells of mammals, including the rabbit 20 and the mouse. 22 I Ca,T is also expressed in the cardiac conduction system, the rabbit AVN, 18 and in canine Purkinje cells. 23, 24 The functional role of I Ca,T in the cardiac primary pacemaker and conduction tissue remains to be elucidated.
Molecular cloning of 3 T-type Ca 2ϩ channel pore-forming subunits, namely the Ca V 3.1/␣ 1G , Ca V 3.2/␣ 1H , and Ca V 3.3/␣ 1I subunits, has fostered investigation of the role of native I Ca,T . 25 Here, we describe that Ca V 3.1 knockout (Ca V 3.1 Ϫ/Ϫ ) mice lack I Ca,T in both SAN pacemaker and AVN cells and display slowed pacemaker activity and AV conduction. Our results constitute the first direct functional demonstration of the participation of Ca v 3.1 channels in pacemaking and cardiac conduction.
Materials and Methods
The generation of the Ca V 3.1 Ϫ/Ϫ mouse line was originally described by Kim et al. 26 The experimental procedure for electrophysiological recording of isolated cells from the SAN, the AVN, and the RA is described in the expanded Materials and Methods section in the online data supplement, available at http://circres.ahajournals.org. Detailed procedures for in vivo surface and intracardiac electrocardiograms (ECGs), measurement of blood pressure, RT-PCR, and quantitative RT-PCR experiments (supplemental Figure II) and numerical modeling of pacemaker activity are available in the expanded online Materials and Methods section. Results are presented as the meanϮSEM. Statistical significance was assessed by the unpaired Student's t test. A value of PϽ0.05 was considered as statistically significant. N indicates the number of mice used and n the number of cells considered.
Results

Ca V 3.1 ؊/؊ SAN Pacemaker Cells Lack I Ca,T
Electrophysiological recordings obtained on SAN cells of wild-type (WT) and Ca V 3.1 Ϫ/Ϫ animals revealed that I Ca,T related to Ca V 3.1 is a major component of the total Ca 2ϩ current (I Ca ) in SAN cells ( Figure 1 ). Figure 1A shows representative I Ca traces recorded from a holding potential (HP) of Ϫ90 mV in WT ( Figure 1Aa ) and Ca V 3.1 Ϫ/Ϫ ( Figure  1Ab ) SAN cells. No difference in the cell capacitance was detected (see supplementary Figure I ). Corresponding current-voltage (I-V) curves are presented in Figure 1B (filled symbols). I Ca,L was measured by applying depolarizing steps from a HP of Ϫ55 mV ( Figure 1B , open symbols), revealing I Ca,T by subtraction of records from a HP of Ϫ55 mV from those obtained from a HP of Ϫ90 mV (Figure 1Ba , dotted line). Consistently, switching the HP from Ϫ90 to Ϫ55 mV significantly shifted I Ca voltage for half activation (V 0.5act ) to more positive values (Ϫ45Ϯ1 mV; kϭ5.7Ϯ0.6 mV from a HP of Ϫ90 mV and Ϫ28Ϯ1 mV; kϭ6.3Ϯ0.3 mV from a HP of Ϫ55 mV, Nϭ9, nϭ17, PϽ0.05) in all tested cells (nϭ17), revealing further a V 0.5act of Ϫ47Ϯ1 mV for the net I Ca,T (Figure 1Ba , dotted line). In contrast to WT SAN cells, none Figure  1Bb ). Indeed, in Ca V 3.1 Ϫ/Ϫ SAN cells, switching to a HP of Ϫ55 mV did not alter significantly voltage dependence of I Ca activation (HP, Ϫ90 mV: V 0.5act ϭϪ30Ϯ1 mV; kϭ8.0Ϯ1.3 mV, nϭ14; and HP Ϫ55 mV: Ϫ28Ϯ1 mV; kϭ6.3Ϯ0.3 mV, Nϭ10, nϭ15, PϭNS). Subtraction between traces from HP Ϫ90 mV and from HP Ϫ55 mV identified no residual I Ca,T , because current waveforms displayed slow inactivation kinetics (Figure 1Bb , inset) and no criss-crossing of the current traces. A comparison of the current density values in WT and Ca V 3.1 Ϫ/Ϫ SAN cells at HP Ϫ90 mV is shown in Figure 1C (black and white bars, respectively) to estimate the I Ca,T component related to Ca v 3.1. At Ϫ40 mV, I Ca,T density was 6.8Ϯ1.6 pA/pF (ϩ/ϩ, Nϭ9, nϭ18) and I Ca,L density was 2.6Ϯ0.7 pA/pF, (Ϫ/Ϫ, Nϭ10, nϭ14). I Ca,L density was not significantly affected by inactivation of Ca v 3.1 channels ( Figure 1D ). Indeed, I Ca,L peak densities at Ϫ10 mV (HP, Ϫ55 mV) were 6.0Ϯ1.6 pA/pF, Nϭ9, nϭ15; and 4.5Ϯ0.6 pA/pF, Nϭ10, nϭ11 in Ca V 3.1 Ϫ/Ϫ and WT SAN cells, respectively. Taken together, these data showed that inactivation of Ca v 3.1 channels abolished I Ca,T and had no significant effect on I Ca,L in SAN cells.
To determine whether the pharmacological sensitivity of the SAN I Ca,T is consistent with the expression of the Ca v 3.1 subunit, we tested its sensitivity to Ni 2ϩ ions (Figure 2A and 2B). Application of Ni 2ϩ concentrations of 50 and 200 mol/L inhibited 26Ϯ9% (Nϭ2, nϭ4) and 61Ϯ10% (nϭ9) of I Ca,T , respectively. Because the IC 50 values for Ni 2ϩ on recombinant Ca V 3.1 and Ca V 3.2 T-type channels are in the range of 100 to 200 mol/L and 5 to 10 mol/L, respectively, 27 these results indicate that I Ca,T in mouse adult SAN cells is generated by the Ca V 3.1 subunit. Consistent with these findings, real-time RT-PCR experiments showed that the Ca v 3.1 subunit is the predominant T-type Ca 2ϩ channel isotype in the SAN of the adult mouse (supplemental Figure  II) . Furthermore, application of 2 mol/L of the 1,4-dihydropyridine I Ca,L blocker isradipine on Ca v 3.1 Ϫ/Ϫ SAN cells blocked I Ca by 93Ϯ4% (Nϭ5, nϭ7, Figure 2C and 2E) from a HP of Ϫ90 mV and by 100% from a HP of Ϫ55 mV (Nϭ5, nϭ8, Figure 2D and 2F). Such a sensitivity to isradipine further confirmed that the remaining I Ca in SAN cells from Ca V 3.1 Ϫ/Ϫ mice was I Ca,L .
Sedated Ca V 3.1 ؊/؊ Mice Have Intrinsic Slower Heart Rate and Prolonged AV Conduction
We next performed surface ECG recordings on sedated WT and Ca V 3.1 Ϫ/Ϫ mice ( Figure 3 ). Because the heart rate is highly regulated by the balance between the sympathetic and vagal input, which depends on the levels of stress and anesthesia, ECGs were also recorded after injection of propranolol and atropine to block the autonomic nervous system (ANS). 28 Recording examples collected from WT (ϩ/ϩ) and Ca V 3.1 Ϫ/Ϫ (Ϫ/Ϫ) mice before and after the ANS block are presented in Figure 3A . The loss of the Ca V 3.1 subunit induced a significant (9%) prolongation of the atrioventricular conduction (PQ interval) under baseline conditions (34Ϯ1 ms, Nϭ11, and 37Ϯ1 ms, Nϭ12 for WT and Ca V 3.1 Ϫ/Ϫ mice, respectively; PϽ0.05). The heart beat (RR interval), P wave duration, and QRS interval ( Figure 3B ), as well as the QTc interval (data not shown; 62Ϯ1 ms and 61Ϯ1 ms for WT and Ca V 3.1 Ϫ/Ϫ mice, respectively; PϾ0.05), were not significantly modified. In conditions of ANS block, the intrinsic heart rate was significantly slowed by Ϸ10%. Indeed, the RR interval was significantly longer in Ca V 3.1 Ϫ/Ϫ mice than in WT animals (144Ϯ2 ms and 132Ϯ2 ms, respectively; PϽ0.05; Figure 3B ). The PQ interval was also markedly prolonged (34Ϯ1 ms and 40Ϯ1 ms in WT and Ca V 3.1 Ϫ/Ϫ animals, respectively; PϽ0.001; Figure 4B ). The other ECG parameters were not significantly modified.
SAN Cells From Ca V 3.1 ؊/؊ Mice Display Slowed Pacemaker Activity
The spontaneous activity of isolated SAN cells was studied to evaluate whether the slowing of the intrinsic heart rate observed in vivo in Ca V 3.1 Ϫ/Ϫ mice was associated with dysfunction of SAN cell automaticity. Representative recordings obtained on WT and Ca V 3.1 Ϫ/Ϫ SAN cells are presented in Figure 4A (upper and lower traces, respectively). Analysis of these recordings showed that inactivation of cacna1g gene resulted in a 37% slowing of the cellular beating rate (163Ϯ13 bpm, Nϭ4, nϭ15 in Ca V 3.1 Ϫ/Ϫ , and 234Ϯ19 bpm, Nϭ5, nϭ14 in SAN cells from WT mice; PϽ0.01; Figure  4B ). Slowing of cellular pacemaking was accompanied by a reduction of the diastolic depolarization slope of Ϸ44% ( Figure 4C ). No significant changes in the maximum diastolic potential (MDP) and the voltage threshold of the action potential upstroke (E th ) were observed (MDP: Ϫ56.9Ϯ1.3 mV in WT, nϭ15, and Ϫ58.2Ϯ1.4 mV for Ca V 3.1 Ϫ/Ϫ SAN cells, nϭ14; E th : Ϫ45Ϯ1.3 mV in WT and Ϫ43Ϯ1.4 mV in Ca V 3.1 Ϫ/Ϫ SAN cells; Figure 4D ). Also, the action potential duration (147Ϯ15 and 141Ϯ10 ms for Ca V 3.1 Ϫ/Ϫ and WT SAN cells, respectively; Figure 4E ) and the action potential amplitude (APA) (92Ϯ8 and 90Ϯ8 mV for Ca V 3.1 Ϫ/Ϫ and WT SAN cells, respectively; not shown) were comparable in SAN cells from WT and Ca v 3.1 Ϫ/Ϫ mice.
Intracardiac Electrophysiology Study of Ca V 3.1 ؊/؊ Mice
The AV conduction delay in mice lacking Ca v 3.1 channels was measured under baseline intracardiac recording conditions. Eight of 10 WT and 7 of 9 Ca V 3.1 Ϫ/Ϫ mice had a distinctly visible His-bundle electrogram ( Figure 5A ). In this group of animals, atrial-His (AH) conduction times were significantly longer in Ca V 3.1 Ϫ/Ϫ mice (31Ϯ1 ms) than in WT animals (25Ϯ1 ms; PϽ0.001; Figure 5B ). However, Hisventricle (HV) intervals were comparable (11Ϯ1 and 10Ϯ1 ms for WT and Ca V 3.1 Ϫ/Ϫ mice, respectively; PϾ0.05). Effective refractory periods at the atrial (AERP), atrioventricular (AVERP), and ventricular (VERP) levels were investigated at a basic cycle length of 100 ms ( Figure 5C ). AERP and VERP were not significantly different between WT and Ca v 3.1 Ϫ/Ϫ mice. In contrast, the AVERP was significantly longer in Ca V 3.1 Ϫ/Ϫ mice (58Ϯ6 ms; Nϭ8) than in WT animals (44Ϯ2 ms; Nϭ10; PϽ0.05). Decremental atrial pacing revealed that Wenckebach cycle length was significantly longer in Ca V 3.1 Ϫ/Ϫ mice than in WT mice (85Ϯ5 ms and 67Ϯ2 ms, respectively; PϽ0.01; Figure 5C ). Atrial pacing confirmed SAN dysfunction. Indeed, the corrected SAN recovery time (cSNRT) was longer in Ca V 3.1 Ϫ/Ϫ mice than in WT mice (31Ϯ5 in Ca v 3.1 Ϫ/Ϫ and 17Ϯ2 ms in WT mice PϽ0.05; nϭ7 and 9, respectively).
AVN Cells From Ca V 3.1 ؊/؊ Mice Lack I Ca,T
We then tested whether dysfunction of AV conduction observed on inactivation of Ca v 3.1 channels was associated with downregulation of I Ca,T in the AVN. I Ca,T and I Ca,L were recorded in isolated AVN cells using the same recording protocols as for SAN cells (Figure 6 ). I Ca,T was found in all the WT AVN cells investigated ( Figure 6A ). Indeed, switching the HP from Ϫ90 to Ϫ60 mV significantly shifted the V 0.5act of the total I Ca from Ϫ34Ϯ0.7 to Ϫ23Ϯ0.8 mV (nϭ7, PϽ0.05). In contrast, no I Ca,T could be recorded in Ca v 3.1 Ϫ/Ϫ AVN cells (Figure 6Ab) , and switching the HP from Ϫ90 to Ϫ60 mV did not shift the V 0.5act value (Ϫ25Ϯ1.3 mV to Ϫ27Ϯ0.8 mV, respectively; PϭNS; Figure 6Bb ). The peak density of the residual I Ca measured from a HP of Ϫ60 mV in AVN cells was not altered by inactivation of Ca v 3.1 channels (4.1Ϯ0.5 pA/pF, Nϭ5, nϭ7 in WT and 4.6Ϯ0.7 pA/pF, Nϭ4, nϭ7 in Ca v 3.1 Ϫ/Ϫ ; PϭNS). In addition, no I Ca,T could be detected in isolated cells from the RA of WT adult mice ( Figure 6C and 6D) , because switching the HP from Ϫ100 to Ϫ50 mV produced no change both in the V 0.5act (Ϫ16Ϯ2 and Ϫ17Ϯ1 mV, Nϭ3, nϭ8, PϭNS; Figure 6D ) and in the peak density (6.9Ϯ1.5 and 7Ϯ1 pA/pF, Nϭ3, nϭ8, PϭNS; Figure  6C ).
Bradycardia in Conscious Unrestrained Ca V 3.1 ؊/؊ Mice
Both the heart rate and the AV conduction were altered in freely moving Ca V 3.1 Ϫ/Ϫ mice ( Figure 7A and 7B and the Table) . The mean heart rate was significantly slowed in Ca V 3.1 Ϫ/Ϫ mice, when considering a 24-hour period or during the day and night periods ( Figure 7B and the Table) . The maximum cardiac frequency during short periods of activity (40 seconds) was unchanged (Table) , suggesting that activation of other ionic channels involved in SAN automaticity can compensate for the lack of I Ca,T during strong activation of the sympathetic nervous system. Spectral analysis of RR signals in the frequency domain revealed no differences between the 2 groups of mice. Total spectral power, ultralow (ULF), very-low (VLF), low (LF), and high (HF) frequencies were not significantly modified between WT and Ca V 3.1 Ϫ/Ϫ mice ( Figure 7C , data not shown for ULF and VLF), indicating that the degree of autonomic regulation of heart rate was not altered in Ca V 3.1 Ϫ/Ϫ mice.
Telemetric recordings also confirmed the prolongation of the PQ interval in Cav3.1 Ϫ/Ϫ mice (Table) , demonstrating that the propagation of the heartbeat through the AV conduction system was delayed in Ca V 3.1 Ϫ/Ϫ mice. This effect was independent from the heart rate because measurements were performed at comparable heart rates (600 bpm; cycle length of 100 ms). In contrast, the atrial conduction (as assessed by the P wave duration), the ventricular conduction (QRS interval), and ventricular repolarization (QT interval) were unchanged (Table) . In addition, we did not find evidence for cardiac arrhythmias in Ca V 3.1 Ϫ/Ϫ mice. Also, no significant difference in the systolic, diastolic, and mean arterial pressure (60Ϯ8 mm Hg, Nϭ8 in WT and 72Ϯ5 mm Hg, Nϭ8 in Ca v 3.1 Ϫ/Ϫ mice; PϭNS) was observed between the 2 mouse strains ( Figure 7D ).
Discussion
The major finding of this study is that genetic inactivation of the Ca V 3.1/␣ 1G T-type Ca 2ϩ channels in mice results in a significant slowing of the heart rate and AV conduction. Downregulation of I Ca,T in both SAN and AVN cells of Ca V 3.1 Ϫ/Ϫ animals is documented, accounting for this in vivo phenotype. The lack of Ca v 3.1 channels in isolated SAN cells induces slowing of pacemaker activity through a reduction of the slope of the diastolic depolarization. Our study provides novel and compelling genetic evidence for a direct contribution of Ca v 3.1 channels in the setting of the mammalian cardiac impulse generation and propagation by contributing to both the diastolic depolarization in the SAN and impulse conduction through the AVN. 
I Ca,T in SAN and AVN Cells Following Inactivation of Ca v 3.1 Channels
A striking observation of this study is that I Ca,T in the mouse SAN is predominantly generated by the Ca V 3.1 subunit because we found no evidence for a residual I Ca,T in Ca v 3.1 Ϫ/Ϫ mice in both SAN (Figure 1 ) and AVN cells ( Figure 6) . The low sensitivity of SAN I Ca,T to Ni 2ϩ is consistent with that observed on recombinant Ca v 3.1-mediated I Ca,T . 27 Also consistent with our general findings is the recent observation that Ca V 3.2 Ϫ/Ϫ mice showed no ECG alterations. 29 
Bradycardia and Atrioventricular Dysfunction in Ca v 3.1 ؊/؊ Mice
ECGs and intracardiac recordings document both bradycardia and slowing of the atrioventricular conduction in Ca V 3.1 Ϫ/Ϫ mice. Several lines of evidence indicate that bradycardia is attributable to slowing of the pacemaker activity in the SAN. First, bradycardia was evident in sedated mice under pharmacological blockade of the ANS input for heart rates that were comparable with the mean heart rate observed in freely moving mice. Second, slowing of the heart rate was observed in freely moving mice in the absence of a significant change both in the heart rate variability profile and in the arterial blood pressure, thus arguing against the hypothesis that bradycardia would be caused by dysfunction in the autonomic regulation of the heart rate or could be secondary to a change in the control of the vascular tone. The prolongation of the SAN recovery time also indicates dysfunction in SAN automaticity. Finally, the slowing of pacemaker activity observed in isolated SAN pacemaker cells of Ca v 3.1 Ϫ/Ϫ mice is consistent with bradycardia being attributable to the lack of I Ca,T in the SAN. The reduction of the mean heart rate measured on freely moving Ca v 3.1 Ϫ/Ϫ mice is moderate, compared with the slowing of the cycle length in isolated pacemaker cells (10% in freely moving mice and 37% in isolated cells). This difference can be caused by the compensatory adrenergic tone in vivo, which stimulates ionic mechanisms involved in pacemaking, such as Ca v 1.3-mediated I Ca,L 9,10 and I f 6 and RyR-dependent diastolic release of Ca 2ϩ . 11 The observation that the maximal heart rate is comparable in WT and Ca v 3.1 Ϫ/Ϫ mice is consistent with this hypothesis. Comparison of mice lacking Ca v 1.3 9 and Ca v 3.1 channels (this study) indicate that I Ca,L and I Ca,T play distinct roles in pacemaker activity in vivo. Indeed, knockout of Ca v 1.3 channels reduces the basal and intrinsic heart rate in sedated conditions by approximately 20% and 60%, respectively, 9 compared with the 10% reduction observed in mice lacking Ca v 3.1 channels in both freely moving and block of ANS conditions. These observations suggest that Ca v 3.1 channels contribute to the setting of the basal heart rate but have less impact on the dynamic regulation of pacemaker activity by the ANS. The lack of a significant change in the variability of the RR intervals in Ca v 3.1 mice is consistent with this hypothesis.
We report that the slowing of the AV conduction in Ca v 3.1 Ϫ/Ϫ mice is caused by dysfunction in the excitability of the AVN. Indeed, intracardiac recordings show a delay in the AH conduction time and AVERP, in the absence of a prolongation of the P wave, which indicates similar conduction velocities in atria from WT and Ca v 3.1 Ϫ/Ϫ mice. Consistently with ECGs and intracardiac recordings, we found no I Ca,T in atrial myocytes from WT mice. Also, AVN cells display I Ca,T related to Ca V 3.1 channels because it was no longer detectable in Ca V 3.1 Ϫ/Ϫ mice. We did not find significant changes in the HV, QRS, and QT intervals (see Figures 3 and 5 and supplemental Figure III) , indicating that the lack of Ca v 3.1 channels does not affect conduction through the His-Purkinje fiber network or the ventricular muscle. This phenotype differs from that of SCN5A ϩ/Ϫ mice, 19 which shows prominent alteration of the P wave and the QRS complex duration, 30 stressing the importance of the cardiac I Na in intraatrial and His-Purkinje conduction. Also in contrast with SCN5A ϩ/Ϫ , 19 Ca v 3.1 Ϫ/Ϫ mice do not present ventricular tachiarrhythmias. This SCN5A-mediated I Na can possibly compensate for the lack of I Ca,T in the His-Purkinje system.
Pacemaking in Ca v 3.1 ؊/؊ Mice
We describe that inactivation of Ca V 3.1 channels significantly prolongs the pacemaker cycle length in isolated SAN cells by reducing the slope of the diastolic depolarization, demonstrating the involvement of Ca v 3.1-mediated I Ca,T in the setting of the diastolic depolarization in mouse SAN cells. In an attempt to compare the physiological roles of Ca v 3.1-mediated I Ca,T with that of Ca v 1.3-mediated I Ca,L and I Na , we have developed a numerical model of mouse SAN electrophysiology based on previous studies on mouse SAN pacemaking in normal and genetically modified mouse strains (see supplemental Figures  IV and V) . Our numerical simulations indicate that Ca v 3.1 channels contribute to pacemaking by activating during the diastolic depolarization for more negative voltages than TTX-sensitive I Na and Ca v 1.3-mediated I Ca,L (see supplemental Figure VB and VE). As a consequence, Ca v 3.1 channels can accelerate the diastolic depolarization rate in a voltage range in which I Na is still not activated. This property can explain, at least in part, how Ca v 3.1 channels can contribute to pacemaking in spite of their relatively low availability at SAN diastolic potentials. An expanded discussion about the development, the features and limitations of our numerical model, and the physiological significance of Ca v 3.1-mediated I Ca,T compared with that of I Ca,L and I Na is available in the online data supplement.
Conclusion
In conclusion, our study demonstrates that Ca V 3.1 channels contribute to the heartbeat by influencing pacemaking and the AV conduction. To date, the presence of T-type channels in human heart is poorly documented. Molecular analyses, such as dot blots and Northern blots of human heart mRNAs, have identified transcripts for Ca V 3.1 and Ca V 3.2. 31, 32 T-type channels may play a role in the human SAN and the conduction system. For instance, the causality between congenital heart block induced by maternal autoantibodies against T-type channels and children showing SAN bradycardia and atrioventricular block has recently been documented. 33 There is growing evidence that T-type channels may constitute a promising pharmacological target for the treatment of human diseases, such as epilepsy and chronic pain. 34 From our observations, T-type channel inhibition would have no deleterious consequences in cardiac physiology. It is, therefore, tempting to speculate that selective blockers of Ca V 3.1 channels may hold promise for the therapeutic management of the cardiac diseases that require moderate heart rate reduction, such as cardiac ischemia and coronary heart disease.
